Evidence map›Paper›PMID 31953933›Full record

ReviewEuropean journal of public health2020

Bringing the commercial determinants of health out of the shadows: a review of how the commercial determinants are represented in conceptual frameworks.

Nason Maani, Jeff Collin, Sharon Friel, Anna B Gilmore, Jim McCambridge, Lindsay Robertson, Mark P Petticrew

Abstract readReview
In one paragraph

Review in European journal of public health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Commercial determinants of health: an ethical exploration.International journal of public health · 2020
    Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Harmful Marketing: An Overlooked Social Determinant of Health.Prevention science : the official journal of the Society for Prevention Research · 2025
    Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Nason MaaniLondon School of Hygiene and Tropical Medicine, London, UK.
Jeff CollinGlobal Health Policy Unit, School of Social and Political Science, University of Edinburgh, Edinburgh, UK.
Sharon FrielSPECTRUM Consortium, UK.
Anna B GilmoreSPECTRUM Consortium, UK.
Jim McCambridgeDepartment of Health Sciences, University of York, Heslington, York, UK.
Lindsay RobertsonSPECTRUM Consortium, UK.
Mark P PetticrewLondon School of Hygiene and Tropical Medicine, London, UK.

Funding

British Heart FoundationCancer Research UKMedical Research Council MR/S037519/1Wellcome Trust 200321/Z/15/Z
6 · The paper itself

Abstract

backgroundThe term 'commercial determinants of health' (CDOH) is increasingly focussing attention upon the role of tobacco, alcohol and food and beverage companies and others-as important drivers of non-communicable diseases (NCDs). However, the CDOH do not seem to be clearly represented in the most common social determinants of health (SDOH) frameworks. We review a wide range of existing frameworks of the determinants of health to determine whether and how commercial determinants are incorporated into current SDOH thinking.

methodsWe searched for papers and non-academic reports published in English since 2000 describing influences on population health outcomes. We included documents with a formal conceptual framework or diagram, showing the integration of the different determinants.

resultsForty-eight framework documents were identified. Only one explicitly included the CDOH in a conceptual diagram. Ten papers discussed the commercial determinants in some form in the text only and fourteen described negative impacts of commercial determinants in the text. Twelve discussed positive roles for the private sector in producing harmful commodities. Overall, descriptions of commercial determinants are frequently understated, not made explicit, or simply missing. The role of commercial actors as vectors of NCDs is largely absent or invisible in many of the most influential conceptual diagrams.

conclusionsOur current public health models may risk framing public health problems and solutions in ways that obscure the role that the private sector, in particular large transnational companies, play in shaping the broader environment and individual behaviours, and thus population health outcomes.

Indexed as

CommerceNoncommunicable DiseasesPopulation HealthSocial Determinants of HealthBeveragesHealth PolicyHumansPrivate SectorPublic HealthTobacco Products

Identifiers

PMID31953933
PMCPMC7445044

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.